VectorXcellerator: OXB has selected the first programmes to move forward through VectorXcellerator, supporting earlier collaboration in advanced therapies.

OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture.

Localised Axial Progenitor Cell Populations in the Avian Tail Bud are not Committed to a Posterior Hox Identity

September 17, 2024
View Resource